Podcast Episodes
Back to Search
Immunotherapy for Advanced HCC: Case Series
Episode 59
In this episode, Amit G. Singal, MD, MS, and Lipika Goyal, MD, discuss key considerations key considerations for hepatologists, oncologists, and othe…
4 years, 10 months ago
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From Germany
Episode 58
In this episode, Georgios Gakis, MD, and Mario Wolfgang Kramer, MD, PhD, discuss key data on immune checkpoint inhibitors for urothelial carcinoma in…
4 years, 11 months ago
Managing Toxicities Associated With FGFR Inhibitors in Urothelial Cancer and Beyond
Episode 57
In this episode, Ignacio Durán, MD, PhD, and Alison Birtle, MD, FRCP, FRCR, discuss toxicities associated with FGFR inhibitors used in the treatment …
4 years, 11 months ago
Optimizing the Timing and Sequencing of Regorafenib and TAS-102 for Patients With Metastatic Colorectal Cancer
Episode 56
In this episode, Joleen Hubbard, MD, and John L. Marshall, MD, discuss use of the later-line treatment options regorafenib and TAS-102 for patients w…
4 years, 11 months ago
Expert Answers to Questions on Contemporary Management of Multiple Myeloma
Episode 55
In this episode, Shaji K. Kumar, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD, and Jesús F. San-Miguel, MD, PhD, answer au…
4 years, 11 months ago
Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
Episode 54
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, consider the potential implications of ongoing and planned clinical trials using …
4 years, 11 months ago
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Episode 53
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, discuss the underlying rationale for using PARP inhibitors in combination with ot…
4 years, 11 months ago
Expert Insight on Key Data From SGO 2021 Informing Treatment for Endometrial and Ovarian Cancer
Episode 52
In this episode, Jubilee Brown, MD, and Ursula Matulonis, MD, provide expert perspectives on new data from SGO 2021 presented for endometrial and ova…
5 years ago
Expert Answers to Questions on PARP Inhibition for Prostate Cancer
Episode 51
In this episode, Charles J. Ryan, MD, and Neal D. Shore, MD, FACS, answer questions from a healthcare professional audience on topics related to pros…
5 years ago
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL
Episode 50
In this episode, Jeremy S. Abramson, MD, MMSc, discusses highlights of the key data from ASH 2020 on the treatment of patients with lymphomas/CLL, wi…
5 years ago